Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction-associated steatotic liver disease.

Journal of pediatric gastroenterology and nutrition·2026
Same author

Exploring organic contaminant and natural organic matter interactions across environmental systems using fluorescence spectroscopy: A critical review.

Advances in colloid and interface science·2026
Same author

Evaluation of tissue-specific Bisphenol A accumulation in mussels upon acute exposure: A pilot study.

Marine pollution bulletin·2026
Same author

Exploring the Impact of Polystyrene Microplastic Beads on Male Gonads of the Marine Mussel, Mytilus galloprovincialis.

Environmental toxicology·2025
Same author

Evaluation of potential bioaccumulation of Bisphenol A in the mussel Mytilus galloprovincialis.

Journal of environmental management·2025
Same author

Effectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real-Word, Multicenter Study.

Liver international : official journal of the International Association for the Study of the Liver·2024
Same journal

Mortality Trends and Disparities for the Six Leading Causes of Cancer Death Among Individuals Aged 15-45 Years in the United States, 1999-2023.

Clinics and research in hepatology and gastroenterology·2026
Same journal

Evaluating Performance of Non-Invasive Tests for Fibrosis Detection in MASLD with Type 2 Diabetes Mellitus: Insights from VCTE-Based Assessment.

Clinics and research in hepatology and gastroenterology·2026
Same journal

The Disease Burden of Gastric Cancer in China, 1990-2023: A Comprehensive Analysis and Projections to 2035.

Clinics and research in hepatology and gastroenterology·2026
Same journal

Safety and efficacy of hepatic arterial infusion chemotherapy combined with camrelizumab and apatinib for advanced hepatocellular Carcinoma: a retrospective clinical analysis.

Clinics and research in hepatology and gastroenterology·2026
Same journal

No papilla, no problem? Primary above-the-cancer needle-knife fistulotomy vis-à-vis papillary cancer.

Clinics and research in hepatology and gastroenterology·2026
Same journal

Burden and distribution of multidrug-resistant bacteria among hospitalized patients with cirrhosis: A systematic review and meta-analysis.

Clinics and research in hepatology and gastroenterology·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Autoimmune hepatitis: current knowledge.

Pietro Vajro1, Giulia Paolella

  • 1Medical School of Salerno, Salerno, Italy. pvajro@unisa.it

Clinics and Research in Hepatology and Gastroenterology
|April 24, 2012
PubMed
Summary
This summary is machine-generated.

Autoimmune hepatitis in children presents as type 1 or type 2, diagnosed via autoantibodies and histology. Treatment with steroids and azathioprine is effective, though relapses and long-term management are common.

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: May 23, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Hepatology

Background:

  • Autoimmune hepatitis (AIH) in children is classified into two types based on autoantibody profiles.
  • Type 1 AIH is associated with antinuclear (ANA) or anti-smooth muscle antibodies (ASMA), often seen in adolescent girls.
  • Type 2 AIH involves anti-liver-kidney microsomes 1 (anti-LKM1) and/or anti-liver cytosol 1 (anti-LC1) antibodies, typically in younger children.

Purpose of the Study:

  • To outline the classification, diagnosis, and management of autoimmune hepatitis in pediatric patients.
  • To highlight the diagnostic criteria and therapeutic strategies for childhood AIH.
  • To discuss the prognosis and potential complications of AIH in children.

Main Methods:

  • Diagnosis relies on serological testing for specific autoantibodies, including ANA, ASMA, anti-LKM1, and anti-LC1.
  • Liver biopsy (histology) is crucial for confirming the diagnosis and assessing disease severity.
  • Treatment protocols involve immunosuppressive agents such as corticosteroids and azathioprine.

Main Results:

  • Autoimmune hepatitis in children is categorized into type 1 and type 2, distinguished by specific autoantibody markers.
  • Concurrent autoimmune diseases may be present in affected children or their family members.
  • Immunosuppressive therapy, primarily with steroids and azathioprine, demonstrates efficacy in most cases, with cyclosporine A also showing success.

Conclusions:

  • Autoimmune hepatitis in children requires accurate diagnosis through autoantibody testing and histology.
  • While effective, treatment for childhood AIH often involves long-term management due to frequent relapses.
  • Liver transplantation remains a rare intervention for pediatric autoimmune hepatitis, underscoring the effectiveness of medical therapies.